European Psychiatry: Volume 17 - Issue S1

European Psychiatry

Only show content I have access to (961)

Over 3 years (961)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Volume 17 - Issue S1 - May 2002

P45. Psychotic disorders - schizophrenia

Posters, Tuesday, 7 May 2002

Ziprasidone vs olanzapine in schizophrenia: a 6-month extension study

Patient knowledge about schizophrenia and treatment compliance

Neuropsychological function in schizophrenia

Gender and clinical symptoms in schizophrenia

Plasma concentrations of amino acids in chronic schizophrenics

P300 Brain Microstate in deficit and nondeficit schizophrenia

Neurological soft signs (NSS) in schizophrenia

Biochemical origin of the schizophrenia and of the behavioral pathologies of schizoid type

P46. Psychopharmacology - clinical

Posters, Tuesday, 7 May 2002

Pharmacokinetics of psychotropics

Valproic acid in unstable mood disorder

Atypical antipsychotics in schizophrenia; efficacy and effect on serotonergic parameters

Citalopram in mentally retarded patients with depression

Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder

Relation between sexual dysfunctions and CYP 2D6 activity

A rare case of neuroleptic malignant syndrome and the NMS spectrum concept

The effect of olanzapine on dopamine receptor responsivity in schizophrenia

Psychopharmacotherapy or psychotherapy of anxiety disorders – one year results

Synthesis of endogenous ethanol during treatment of alcoholic dependence

Creatine kinase levels during treatment with atypical antipsychotic agents

Alteration of hormone status during the treatment of risperidon

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Volume 17 - Issue S1 - May 2002

P45. Psychotic disorders - schizophrenia

Posters, Tuesday, 7 May 2002

P46. Psychopharmacology - clinical

Posters, Tuesday, 7 May 2002